2022
DOI: 10.1016/j.ultrasmedbio.2022.03.016
|View full text |Cite
|
Sign up to set email alerts
|

Blood Flow Quantification with High-Frame-Rate, Contrast-Enhanced Ultrasound Velocimetry in Stented Aortoiliac Arteries: In Vivo Feasibility

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 28 publications
0
0
0
Order By: Relevance
“…49,50 The feasibility of ePIV and CFD in patients with atherosclerosis has already been shown in small patient populations. 16,47,48,51,52 However, longitudinal studies with larger cohorts are necessary to show the potential benefit of these novel modalities in clinical practice and to study the relation between vector derived parameters and clinical outcome.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…49,50 The feasibility of ePIV and CFD in patients with atherosclerosis has already been shown in small patient populations. 16,47,48,51,52 However, longitudinal studies with larger cohorts are necessary to show the potential benefit of these novel modalities in clinical practice and to study the relation between vector derived parameters and clinical outcome.…”
Section: Discussionmentioning
confidence: 99%
“…An extra potential benefit of CFD models is the ability to predict the effect of different treatment strategies on local hemodynamics to select a treatment that creates an optimal hemodynamic environment, with the aim to reduce reintervention rates 49 , 50 . The feasibility of ePIV and CFD in patients with atherosclerosis has already been shown in small patient populations 16 , 47 , 48 , 51 , 52 . However, longitudinal studies with larger cohorts are necessary to show the potential benefit of these novel modalities in clinical practice and to study the relation between vector derived parameters and clinical outcome.…”
Section: Discussionmentioning
confidence: 99%